These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 22389253

  • 1. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.
    Thol F, Kade S, Schlarmann C, Löffeld P, Morgan M, Krauter J, Wlodarski MW, Kölking B, Wichmann M, Görlich K, Göhring G, Bug G, Ottmann O, Niemeyer CM, Hofmann WK, Schlegelberger B, Ganser A, Heuser M.
    Blood; 2012 Apr 12; 119(15):3578-84. PubMed ID: 22389253
    [Abstract] [Full Text] [Related]

  • 2. Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome.
    Hong JY, Seo JY, Kim SH, Jung HA, Park S, Kim K, Jung CW, Kim JS, Park JS, Kim HJ, Jang JH.
    Anticancer Res; 2015 May 12; 35(5):3081-9. PubMed ID: 25964599
    [Abstract] [Full Text] [Related]

  • 3. Effect of RNA splicing machinery gene mutations on prognosis of patients with MDS: A meta-analysis.
    Wang X, Song X, Yan X.
    Medicine (Baltimore); 2019 May 12; 98(21):e15743. PubMed ID: 31124956
    [Abstract] [Full Text] [Related]

  • 4. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts.
    Kang MG, Kim HR, Seo BY, Lee JH, Choi SY, Kim SH, Shin JH, Suh SP, Ahn JS, Shin MG.
    BMC Cancer; 2015 Jun 27; 15():484. PubMed ID: 26115659
    [Abstract] [Full Text] [Related]

  • 5. Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes.
    Wu L, Song L, Xu L, Chang C, Xu F, Wu D, He Q, Su J, Zhou L, Xiao C, Zhang Z, Zhao Y, Chen S, Li X.
    Tumour Biol; 2016 Apr 27; 37(4):4633-40. PubMed ID: 26508027
    [Abstract] [Full Text] [Related]

  • 6. Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.
    Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C, Della Valle V, Couronné L, Scourzic L, Chesnais V, Guerci-Bresler A, Slama B, Beyne-Rauzy O, Schmidt-Tanguy A, Stamatoullas-Bastard A, Dreyfus F, Prébet T, de Botton S, Vey N, Morgan MA, Cross NC, Preudhomme C, Birnbaum D, Bernard OA, Fontenay M, Groupe Francophone des Myélodysplasies.
    Blood; 2012 Apr 05; 119(14):3211-8. PubMed ID: 22343920
    [Abstract] [Full Text] [Related]

  • 7. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.
    Je EM, Yoo NJ, Kim YJ, Kim MS, Lee SH.
    Int J Cancer; 2013 Jul 05; 133(1):260-5. PubMed ID: 23280334
    [Abstract] [Full Text] [Related]

  • 8. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.
    Patnaik MM, Lasho TL, Finke CM, Hanson CA, Hodnefield JM, Knudson RA, Ketterling RP, Pardanani A, Tefferi A.
    Am J Hematol; 2013 Mar 05; 88(3):201-6. PubMed ID: 23335386
    [Abstract] [Full Text] [Related]

  • 9. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
    Ohgami RS, Ma L, Merker JD, Gotlib JR, Schrijver I, Zehnder JL, Arber DA.
    Mod Pathol; 2015 May 05; 28(5):706-14. PubMed ID: 25412851
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome.
    Nagehan P, Sabbir M, Song J, Mohammad H.
    J Clin Exp Hematop; 2023 May 05; 63(3):173-176. PubMed ID: 37766563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
    Choi HW, Kim HR, Baek HJ, Kook H, Cho D, Shin JH, Suh SP, Ryang DW, Shin MG.
    Ann Lab Med; 2015 Jan 05; 35(1):118-22. PubMed ID: 25553291
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome.
    Wang M, Chen P, Li D, Zhao M.
    Mol Biol Rep; 2024 Sep 15; 51(1):985. PubMed ID: 39278886
    [Abstract] [Full Text] [Related]

  • 19. The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
    Chiereghin C, Travaglino E, Zampini M, Saba E, Saitta C, Riva E, Bersanelli M, Della Porta MG.
    Genes (Basel); 2021 Jul 27; 12(8):. PubMed ID: 34440317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.